Higher expression of G9a is correlated better with long-term survival of lung adenocarcinoma, and G9a inhibition enhances generation of the tumor-propagating cell phenotype to further promote metastasis and tumor progression (Rowbotham et al., 2018). Here, EHMT2 is linked to lung adenocarcinoma.